New patent expiration for Novartis Pharms drug ENTRESTO
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one […]
New patent expiration for Novartis Pharms drug ENTRESTO Read Post »
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one […]
New patent expiration for Novartis Pharms drug ENTRESTO Read Post »
Annual Drug Patent Expirations for AXIRON Axiron is a drug marketed by Eli Lilly And Co and is included in
AXIRON (testosterone) Eli lilly and co Patent: 8,784,878 Expiration: Jul 13, 2023 See More … For more information on how
Drug Patent Expirations for the Week of July 9, 2023 Read Post »
Annual Drug Patent Expirations for VISTOGARD Vistogard is a drug marketed by Wellstat Therap and is included in one NDA.
New patent expiration for Wellstat Therap drug VISTOGARD Read Post »
Annual Drug Patent Expirations for XURIDEN Xuriden is a drug marketed by Wellstat Therap and is included in one NDA.
New patent expiration for Wellstat Therap drug XURIDEN Read Post »
Annual Drug Patent Expirations for XTAMPZA+ER Xtampza Er is a drug marketed by Collegium Pharm Inc and is included in
New patent expiration for Collegium Pharm drug XTAMPZA ER Read Post »
LEVITRA (vardenafil hydrochloride) Bayer hlthcare Patent: 8,841,446 Expiration: Jul 3, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of July 2, 2023 Read Post »
Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one
New patent expiration for Eyepoint Pharms drug DEXYCU KIT Read Post »
Annual Drug Patent Expirations for LEVITRA Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug LEVITRA Read Post »
Get fresh news and insights, drug patent expirations & more…